TargImmune Therapeutics

TargImmune Therapeutics Develops Molecular-Based Models Aimed at Assisting Drug Development for New Targeted Cancer Treatments. The company focuses on the research, development, manufacturing, procurement, and sales of pharmaceutical and diagnostic products and technologies, with an emphasis on the development of novel cancer-targeting technologies that utilize non-viral vectors to target and destroy cancer cells, enabling the healthcare sector to leverage unique drugs and therapies in the fields of immuno-oncology and personalized treatment.